CASEID,PRIMARYID,CASEVERSION,I_F_CODE,EVENT_DT,MFR_DT,INIT_FDA_DT,FDA_DT,REPT_COD,AUTH_NUM,MFR_NUM,MFR_SNDR,LIT_REF,AGE,AGE_COD,AGE_GRP,SEX,E_SUB,WT,WT_COD,REPT_DT,TO_MFR,OCCP_COD,REPORTER_COUNTRY,OCCR_COUNTRY,DRUGNAME,PT,PRIMARYID_OUTC,OUTC_COD,PRIMARYID_RPSR,RPSR_COD,PRIMARYID_THER,DSG_DRUG_SEQ,START_DT,END_DT,DUR,DUR_COD,PRIMARYID_INDI,INDI_DRUG_SEQ,INDI_PT
11991033,1199103320,20,F,,20240416,20160202,20240424,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004939,BRISTOL MYERS SQUIBB,Literature citation unavailable,54,YR,A,M,Y,,,20240424,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Loss of personal independence in daily activities;Off label use;Paranoia;Prescribed overdose;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,1199103320,HO,,,,,,,,,1199103320,1,HIV infection
12161166,121611667,7,F,,20220929,20160308,20240418,EXP,,CA-ABBVIE-10P-163-0641882-00,ABBVIE,"Pfeffer G, Cote H, Montaner J, et al. Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving hiv therapy. Neurology. 2009;73:71-72.",52,YR,,M,Y,,,20240418,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,121611667,OT,,,121611667,1,,200802,8,YR,121611667,1,HIV infection
13232338,132323386,6,F,,20240422,20170214,20240429,EXP,,PHHY2017FR019688,NOVARTIS,"Barthelemy A, Bouvier N, Verdon R, Chatelet V, Hurault de Ligny B.. Successful renal retransplantation after graft loss from BK polyomavirus infection in a human immunodeficiency virus-positive patient. TRANSPLANT INFECTIOUS DISEASE. 2016;18 (6):946-9",51,YR,,M,Y,,,20240429,,HP,FR,FR,EFAVIRENZ,Neutropenia;Transplant rejection;Viraemia,132323386,HO,,,132323386,11,,,4,DAY,132323386,1,Immunosuppression
14608010,146080104,4,F,,20240429,20180307,20240507,EXP,,CA-GLAXOSMITHKLINE-CA2018GSK038183,GLAXOSMITHKLINE,,,,,,Y,,,20240507,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia;Progressive external ophthalmoplegia,146080104,OT,,,146080104,1,,,549,DAY,146080104,1,HIV infection
14612446,146124464,4,F,,20240429,20180308,20240507,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2018GSK038183,VIIV,,,,,,Y,,,20240507,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia;Progressive external ophthalmoplegia,146124464,OT,,,146124464,1,,,549,DAY,146124464,1,HIV infection
15548548,155485486,6,F,,20240508,20181025,20240518,EXP,,PT-AUROBINDO-AUR-APL-2018-051917,AUROBINDO,"Santos JV, Soares J, Sarmento A, Costa-Pereira A.. Spontaneous viral clearance in sixteen HIV-infected patients with chronic hepatitis C. Intervirology. 2018;1-8",29,YR,,M,Y,,,20240518,,HP,PT,PT,EFAVIRENZ,Drug-induced liver injury;Hepatic fibrosis;Transaminases increased,155485486,LT,,,,,,,,,155485486,1,Hepatitis C
16206633,162066335,5,F,,20240508,20190417,20240518,EXP,,CA-AUROBINDO-AUR-APL-2019-019815,AUROBINDO,,,,,M,Y,,,20240518,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction,162066335,HO,,,,,,,,,162066335,1,Product used for unknown indication
17044956,1704495618,18,F,,20240523,20191118,20240528,EXP,,CA-BAUSCH-BL-2019-058588,BAUSCH AND LOMB,"Harris M, Larsen G, Montaner J. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22 (14):1890-1892. doi:10.1097/QAD.0b013e32830e0169",54,YR,,M,Y,,,20240528,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Paranoia;Prescribed overdose;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,1704495618,DE,,,1704495618,70,,,4,YR,1704495618,1,Bipolar disorder
17497526,174975268,8,F,20060101,20240501,20200304,20240503,EXP,,US-GILEAD-2020-0452918,GILEAD,,42,YR,A,M,Y,70.748,KG,20240503,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Glomerulonephritis chronic;Pain;Renal failure;Renal tubular necrosis,174975268,HO,,,174975268,1,2006,201808,86,DAY,174975268,1,HIV infection
17917665,179176657,7,F,20100920,20240422,20200619,20240424,EXP,,US-GILEAD-2020-0473759,GILEAD,,59,YR,A,M,Y,76.19,KG,20240424,,LW,US,US,SUSTIVA,Acute kidney injury;Bone density decreased;Chronic kidney disease;End stage renal disease;Fatigue;General physical health deterioration;Hip fracture;Libido decreased;Medical diet;Nephrogenic anaemia;Nephropathy;Osteoporosis;Renal failure,179176657,HO,,,179176657,1,20031206,20040407,123,DAY,179176657,1,HIV infection
18079728,180797283,3,F,,20240510,20200728,20240517,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK143033,VIIV,,,,,,Y,,,20240517,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,180797283,OT,,,,,,,,,180797283,1,Bipolar disorder
18079730,180797303,3,F,,20240510,20200728,20240517,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK143033,GLAXOSMITHKLINE,,,,,,Y,,,20240517,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,180797303,OT,,,,,,,,,180797303,1,Bipolar disorder
18087033,180870333,3,F,,20240510,20200729,20240519,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK142975,VIIV,,,,,,Y,,,20240519,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,180870333,OT,,,,,,,,,180870333,1,Product used for unknown indication
18087039,180870393,3,F,,20240510,20200729,20240519,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK142975,GLAXOSMITHKLINE,,,,,,Y,,,20240519,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,180870393,OT,,,,,,,,,180870393,1,Product used for unknown indication
18194619,181946198,8,F,,20240508,20200825,20240510,EXP,,CA-AstraZeneca-2020SF06767,ASTRAZENECA,,54,YR,,M,Y,,,20240510,,MD,CA,,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities;Off label use,181946198,OT,,,,,,,,,181946198,1,Bipolar disorder
18204398,182043982,2,F,,20240503,20200827,20240506,EXP,,CA-AstraZeneca-2020SF07439,ASTRAZENECA,,,,,M,Y,,,20240506,,MD,CA,,SUSTIVA,Depression;Drug interaction,182043982,DE,,,,,,,,,182043982,1,Product used for unknown indication
18227744,182277443,3,F,,20240510,20200903,20240519,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK176607,GLAXOSMITHKLINE,,,,,,Y,,,20240519,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,182277443,OT,,,,,,,,,182277443,1,Bipolar disorder
18227941,182279413,3,F,,20240510,20200903,20240519,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK176607,VIIV,,,,,,Y,,,20240519,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,182279413,OT,,,,,,,,,182279413,1,Bipolar disorder
18916042,189160423,3,F,,20240428,20210218,20240506,EXP,,AU-JNJFOC-20210220797,JOHNSON AND JOHNSON,,,,,,Y,,,20240506,,HP,AU,AU,EFAVIRENZ,Dyslipidaemia;Hypertension,189160423,OT,,,,,,,,,189160423,1,HIV infection
18930080,189300803,3,F,20070101,20240424,20210223,20240430,EXP,,CA-BAUSCH-BL-2021-005979,BAUSCH AND LOMB,"Harris M, Larsen G, Montaner J. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22 (14):1890-1891. doi:10.1097/QAD.0b013e32830e0169",44,YR,,M,Y,,,20240430,,MD,CA,CA,EFAVIRENZ,Drug interaction;Psychiatric decompensation,189300803,HO,,,189300803,6,20070626,20070522,355,DAY,189300803,1,Depression
19081584,190815849,9,F,20060602,20240415,20210331,20240423,EXP,,CA-AstraZeneca-2020SF04539,ASTRAZENECA,,44,YR,,M,Y,,,20240423,,MD,CA,,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,190815849,HO,,,190815849,1,20070729,20070730,2,DAY,190815849,1,Depression
19229151,192291514,4,F,20150527,20240411,20210506,20240415,PER,,US-GILEAD-2021-0528659,GILEAD,,46,YR,A,M,Y,85.27,KG,20240415,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Blood creatinine increased;Bone density decreased;Emotional distress;Fatigue;Foot fracture;Gait disturbance;Myalgia;Osteopenia;Pain,,,,,192291514,1,200601,201403,,,192291514,1,HIV infection
19894699,198946993,3,F,,20240611,20210929,20240619,EXP,,CA-APOTEX-2021AP043233,APOTEX,,54,YR,,M,Y,,,20240619,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Loss of personal independence in daily activities;Product use in unapproved indication,198946993,OT,,,,,,,,,198946993,1,HIV infection
19938893,1993889322,22,F,,20240618,20211011,20240627,EXP,,CA-MYLANLABS-11P-028-0710272-00,MYLAN,,54,YR,,M,Y,,,20240627,,CN,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Lymphoproliferative disorder;Paranoia;Prescribed overdose;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,1993889322,OT,,,,,,,,,1993889322,1,Bipolar disorder
20432545,204325454,4,F,20130101,20240521,20220204,20240524,EXP,,TR-GILEAD-2022-0568528,GILEAD,,56,YR,A,M,Y,70,KG,20240524,,MD,TR,TR,EFAVIRENZ,Genotype drug resistance test positive;Osteonecrosis;Osteopenia;Osteoporosis;Viraemia,204325454,OT,,,204325454,1,2012,,,,204325454,1,HIV infection
20861199,208611994,4,F,,20240126,20220523,20240612,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-039077,BRISTOL MYERS SQUIBB,Literature citation unavailable.,44,YR,A,M,Y,,,20240612,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Hospitalisation;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208611994,OT,,,,,,,,,208611994,1,HIV infection
20892665,208926658,8,F,,20231205,20220531,20240425,EXP,,CA-ABBVIE-22K-028-4414704-00,ABBVIE,,54,YR,,M,Y,,,20240425,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208926658,HO,,,,,,,,,208926658,1,HIV infection
20898441,208984418,8,F,,20240508,20220601,20240520,EXP,,CA-AUROBINDO-AUR-APL-2022-018761,AUROBINDO,,54,YR,,M,Y,,,20240520,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208984418,HO,,,,,,,,,208984418,1,Psychotic disorder
20910771,209107716,6,F,,20240330,20220603,20240409,EXP,,CA-TEVA-2022-CA-2041639,TEVA,,54,YR,,M,Y,,,20240409,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,209107716,OT,,,,,,,,,209107716,1,HIV infection
21532531,215325315,5,F,,20240410,20221101,20240424,EXP,,IN-CIPLA (EU) LIMITED-2022IN06312,CIPLA,"Lad SG, Pandey V, Kolhe K, Chauhan S, Gattani M, Sethiya P et.al. AIH in HIV: A Very Much Possible Entity. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY. 2022;12 (5):1388 to 1392",,,,,Y,,,20240424,,HP,IN,IN,EFAVIRENZ,Autoimmune hepatitis;Drug-induced liver injury,215325315,OT,,,,,,,,,215325315,1,HIV infection
21984954,219849545,5,F,20211101,20240531,20230213,20240607,EXP,,US-VIIV HEALTHCARE LIMITED-US2023AMR018948,VIIV,,,,,,Y,,,20240607,,HP,US,US,SUSTIVA,Gun shot wound;Hypokinesia;Paralysis;Pyrexia;Skin laceration;Thrombocytopenia;Wound infection,219849545,DS,,,219849545,1,2019,2019,,,219849545,1,HIV infection
22010238,220102382,2,F,,20240429,20230220,20240506,EXP,CA-HEALTH-05970570,CA-VIIV HEALTHCARE LIMITED-CA2023025043,VIIV,,,,,,Y,,,20240506,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,220102382,HO,,,,,,,,,220102382,1,Product used for unknown indication
22010271,220102712,2,F,,20240429,20230220,20240506,EXP,CA-HEALTH-05970570,CA-GSK-CA2023025043,GLAXOSMITHKLINE,,,,,,Y,,,20240506,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,220102712,HO,,,,,,,,,220102712,1,Product used for unknown indication
22298122,222981225,5,F,,20240126,20230509,20240612,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107208,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20240612,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Hospitalisation;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,222981225,HO,,,,,,,,,222981225,1,HIV infection
22356213,223562138,8,F,20230101,20240514,20230523,20240522,EXP,,AR-009507513-2305ARG006540,MERCK,,,,,M,Y,,,20240522,,CN,AR,AR,EFAVIRENZ,Abnormal dreams;Anxiety;Arrhythmia;Drug effect less than expected;Drug hypersensitivity;Drug intolerance;Fear;Nervous system disorder;Product supply issue;Somnolence,223562138,OT,,,223562138,1,2008,202302,,,223562138,1,HIV infection
22639426,226394262,2,F,,20240527,20230626,20240606,EXP,,IT-AUROBINDO-AUR-APL-2023-043613,AUROBINDO,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;1415-1422:78(6)",,,A,,Y,,,20240606,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226394262,OT,,,,,,,,,226394262,1,HIV infection
22639531,226395313,3,F,,20240415,20230626,20240429,EXP,,IT-AUROBINDO-AUR-APL-2023-043201,AUROBINDO,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,A,,Y,,,20240429,,HP,IT,IT,EFAVIRENZ,Drug resistance;Pathogen resistance;Treatment failure;Viraemia;Viral mutation identified;Virologic failure,226395313,OT,,,,,,,,,226395313,1,HIV infection
22646443,226464432,2,F,,20240405,20230627,20240415,EXP,,IT-MYLANLABS-2023M1066778,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,A,,Y,,,20240415,,HP,IT,IT,EFAVIRENZ,Treatment failure,226464432,OT,,,,,,,,,226464432,1,HIV infection
22646473,226464732,2,F,,20240405,20230627,20240415,EXP,,IT-MYLANLABS-2023M1066729,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,A,,Y,,,20240415,,HP,IT,IT,EFAVIRENZ,Treatment failure,226464732,OT,,,,,,,,,226464732,1,HIV infection
22646768,226467682,2,F,,20240405,20230627,20240415,EXP,,IT-MYLANLABS-2023M1066665,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy.. 2023;78(6):1415-1422",,,A,,Y,,,20240415,,HP,IT,IT,EFAVIRENZ,Treatment failure,226467682,OT,,,,,,,,,226467682,1,HIV infection
22646769,226467692,2,F,,20240405,20230627,20240418,EXP,,IT-MYLANLABS-2023M1066656,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy.. 2023;78(6):1415-1422",,,A,,Y,,,20240418,,HP,IT,IT,EFAVIRENZ,Treatment failure,226467692,OT,,,,,,,,,226467692,1,HIV infection
22662983,226629833,3,F,20131227,20240520,20230703,20240527,EXP,,JP-JNJFOC-20181027661,JOHNSON AND JOHNSON,,49,YR,A,M,Y,,,20240527,,MD,JP,JP,EFAVIRENZ,Amoebic dysentery;Beta 2 microglobulin urine increased;Irritable bowel syndrome;Protein urine present,226629833,OT,,,226629833,1,20121018,20181231,7,YR,226629833,1,HIV infection
22739852,227398522,2,F,,20240405,20230722,20240420,EXP,,CA-AUROBINDO-AUR-APL-2023-048696,AUROBINDO,"Lopez A, Bacha J, Kovarik C, Campbell L. Successful use of multidisciplinary palliative care in the outpatient treatment of disseminated histoplasmosis in an hiv positive child. Children-(Basel). 2021;8(4)",10,YR,,F,Y,,,20240420,,HP,CA,CA,EFAVIRENZ,Drug ineffective,227398522,OT,,,,,,,,,227398522,1,HIV infection
22745383,227453832,2,F,,20240408,20230725,20240417,EXP,,CA-APOTEX-2023AP010583,APOTEX,,54,YR,,M,Y,,,20240417,,HP,CA,CA,EFAVIRENZ,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,227453832,OT,,,,,,,,,227453832,1,HIV infection
22818216,228182162,2,F,,20240624,20230814,20240628,EXP,,IN-CIPLA LTD.-2023IN04773,CIPLA,,,,,,Y,,,20240628,,HP,IN,IN,EFAVIRENZ,Foetal exposure during pregnancy;Neural tube defect,228182162,CA,,,,,,,,,,,
22818822,228188222,2,F,20170101,20240615,20230814,20240628,EXP,,ZA-CIPLA (EU) LIMITED-2023ZA04764,CIPLA,,,,,,Y,,,20240628,,HP,ZA,ZA,EFAVIRENZ,Abortion spontaneous;Exposure during pregnancy,228188222,OT,,,228188222,1,20170224,,,,228188222,1,Antiretroviral therapy
23022257,230222572,2,F,,20240410,20231003,20240412,EXP,,CA-SANDOZ INC.-NVSC2023CA037206,SANDOZ,,54,YR,,M,Y,,,20240412,,CN,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,230222572,HO,,,,,,,,,230222572,1,HIV infection
23029234,230292344,4,F,,20240507,20231004,20240508,EXP,,CA-SANDOZ INC.-SDZ2023CA035416,SANDOZ,,54,YR,,M,Y,,,20240508,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,230292344,OT,,,,,,,,,230292344,1,HIV infection
23131537,231315376,6,F,20231001,20240604,20231031,20240627,PER,,US-THERATECHNOLOGIES INC.-2023-THE-IBA-000432,Unknown Manufacturer,,,,,,Y,,,20240627,,CN,US,US,SUSTIVA,Abdominal pain upper;Decreased appetite;Fatigue;Hypoaesthesia;Paraesthesia;Scar,,,,,231315376,1,202310,202310,,,231315376,1,HIV infection
23253196,232531963,3,F,,20240621,20231201,20240627,EXP,,CA-SANDOZ INC.-NVSC2022CA283120,SANDOZ,,54,YR,,M,Y,,,20240627,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Paranoia;Prescribed overdose;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,232531963,OT,,,,,,,,,232531963,1,Mental disorder
23380635,233806352,2,F,,20240415,20240109,20240429,EXP,,IT-AUROBINDO-AUR-APL-2023-043261,AUROBINDO,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,A,,Y,,,20240429,,HP,IT,IT,EFAVIRENZ,Drug resistance;Pathogen resistance;Treatment failure;Viraemia;Viral mutation identified;Virologic failure,233806352,OT,,,,,,,,,233806352,1,HIV infection
23686289,236862892,2,F,,20240326,20240329,20240402,EXP,,RO-MYLANLABS-2024M1027744,MYLAN,"Arbune M, Padurariu-Covit M, Tiutiuca C, Mihailov R, Niculet E, Arbune A, et al.. Unusual localization of aids-related kaposi?s sarcoma in a heterosexual male during the covid-19 pandemic: a case report.. Tropical Medicine and Infectious Disease. 2024;9(2):47",30,YR,,M,Y,,,20240402,,HP,RO,RO,EFAVIRENZ,Febrile neutropenia;Gastroenteritis;Meningitis meningococcal;Staphylococcal infection;Treatment noncompliance;Virologic failure,236862892,OT,,,,,,,,,236862892,1,HIV infection
23690188,236901881,1,I,,20240316,20240401,20240401,EXP,,RO-AUROBINDO-AUR-APL-2024-013763,AUROBINDO,"Arbune M, Padurariu-Covit MD, Tiutiuca C, Mihailov R, Niculet E, Arbune AA, et al.. Unusual localization of aids-related kaposi?s sarcoma in a heterosexual male during the covid-19 pandemic: a case report.. Topical Medicine and Infectious Disease.. 2024;9(2):47",30,YR,,M,Y,,,20240330,,HP,RO,RO,EFAVIRENZ,Drug ineffective;Febrile neutropenia;Gastroenteritis;Meningitis meningococcal;Staphylococcal infection;Treatment noncompliance;Virologic failure,236901881,OT,,,236901881,10,2013,,,,236901881,1,HIV infection
23693254,236932541,1,I,20230801,20240326,20240401,20240401,EXP,,UA-MYLANLABS-2024M1028641,MYLAN,,44,YR,,M,Y,,,20240401,,HP,UA,UA,"EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL",Nephropathy toxic,236932541,OT,,,236932541,1,20220815,20240305,569,DAY,236932541,1,HIV infection CDC Group IV subgroup E
23695703,236957031,1,I,,20240326,20240402,20240402,EXP,,CN-MACLEODS PHARMACEUTICALS US LTD-MAC2024046617,MACLEODS,"Chen Z, Si T, Ying L, Guiying C, Ping XJ, Wang M. A case of multiple ART intolerance responds to Albuvirtide and Dolutegravir: Case report and literature review. Heliyon. 2024;10(6):e27219",,,,,Y,,,20240402,,HP,CN,CN,EFAVIRENZ,Abdominal discomfort;Arthralgia;Decreased appetite;Diarrhoea;Drug intolerance;Drug-induced liver injury;Fatigue;Nausea;Rash;Vomiting,236957031,HO,,,236957031,1,201412,,,,236957031,1,Antiretroviral therapy
23697489,236974891,1,I,,20240327,20240402,20240402,EXP,,CA-MYLANLABS-2024M1029479,MYLAN,"DeKoven S, Naccarato M, Brumme CJ, Tan DHS. Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series. HIV-Med 2023; 24 (11): 1137-1143.",45,YR,,F,Y,,,20240402,,HP,CA,CA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Treatment noncompliance,236974891,OT,,,,,,,,,236974891,1,HIV infection
23700122,237001221,1,I,,20240319,20240403,20240403,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-004631,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20240403,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Hospitalisation;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,237001221,OT,,,,,,,,,237001221,1,HIV infection
23703973,237039731,1,I,,20240327,20240403,20240403,EXP,,CA-STRIDES ARCOLAB LIMITED-2024SP003830,STRIDES,"DeKoven S, Naccarato M, Brumme CJ, Tan DHS.. Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series.. HIV-Med. 2023;24 (11):1137-1143.",45,YR,,F,Y,,,20240404,,HP,CA,CA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Drug ineffective;Treatment noncompliance,237039731,OT,,,,,,,,,237039731,1,HIV infection
23706834,237068341,1,I,,20240328,20240404,20240404,EXP,,DE-MYLANLABS-2024M1030198,MYLAN,"Foerster Y, Sollfrank L, Rechtien L, Harrer T, Berking C, Sticherling M. Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature. Front-Immunol 2023; 14 1-6.",74,YR,,F,Y,,,20240404,,HP,DE,DE,EFAVIRENZ,Pemphigoid,237068341,HO,,,,,,,,,237068341,1,HIV infection
23709559,237095591,1,I,,20240328,20240404,20240404,EXP,,DE-STRIDES ARCOLAB LIMITED-2024SP003931,STRIDES,"Foerster Y, Sollfrank L, Rechtien L, Harrer T, Berking C, Sticherling M.. Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature.. Front-Immunol. 2023;14:1-6",74,YR,,F,Y,,,20240405,,HP,DE,DE,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Pemphigoid,237095591,HO,,,,,,,,,237095591,1,HIV infection
23710640,237106402,2,F,20220601,20240412,20240405,20240419,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2024APC040288,VIIV,,,,,,Y,,,20240419,,CN,CN,CN,EFAVIRENZ,Chronic kidney disease;Dizziness;Fatigue;Hypertension;Hyperuricaemia;Product use in unapproved therapeutic environment;Renal impairment;Treatment failure,237106402,OT,,,237106402,1,202206,,,,237106402,1,HIV infection
23710641,237106412,2,F,20220601,20240412,20240405,20240419,EXP,,CN-GSK-CN2024APC040288,GLAXOSMITHKLINE,,,,,,Y,,,20240419,,CN,CN,CN,EFAVIRENZ,Chronic kidney disease;Dizziness;Fatigue;Hypertension;Hyperuricaemia;Product use in unapproved therapeutic environment;Renal impairment;Treatment failure,237106412,OT,,,237106412,1,202206,,,,237106412,1,HIV infection
23711365,237113651,1,I,,20240322,20240405,20240405,EXP,,GB-AUROBINDO-AUR-APL-2024-014910,AUROBINDO,,,,,M,Y,101,KG,20240405,,HP,GB,GB,EFAVIRENZ,Hepatitis;Liver function test abnormal,237113651,DS,,,,,,,,,237113651,1,Product used for unknown indication
23745957,237459572,2,F,,20240420,20240416,20240429,EXP,,"FR-VELOXIS PHARMACEUTICALS, INC.-2024-VEL-00197",VELOXIS PHARMACEUTICALS,"Barthelemy A, Bouvier N, Verdon R, Chatelet V, Hurault de Ligny B.. Successful renal retransplantation after graft loss from BK polyomavirus infection in a human immunodeficiency virus-positive patient.. Transplant Infectious Disease : An Official Journal of the Transplantation.. 2016;18(6):946-949",51,YR,,M,Y,,,20240429,,MD,FR,FR,EFAVIRENZ,BK virus infection;Donor specific antibody present;Graft complication;Histology abnormal;Neutropenia;Polyomavirus-associated nephropathy;Transplant rejection;Viral test positive,237459572,HO,,,,,,,,,237459572,1,Immunosuppressant drug therapy
23746723,237467232,2,F,,20240415,20240416,20240430,EXP,,CA-AUROBINDO-AUR-APL-2024-016888,AUROBINDO,"DeKoven S, Naccarato M, Brumme CJ, Tan DHS. Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series. HIV-Med. 2023;24(11):1137-1143",45,YR,,F,Y,,,20240430,,HP,CA,CA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Drug ineffective;Treatment noncompliance;Virologic failure,237467232,OT,,,,,,,,,237467232,1,HIV infection
23757124,237571241,1,I,,20240408,20240418,20240418,EXP,,FR-SANDOZ INC.-PHHY2017FR019688,SANDOZ,,51,YR,,M,Y,,,20240418,,MD,FR,FR,EFAVIRENZ,BK virus infection;Donor specific antibody present;Graft complication;Histology abnormal;Neutropenia;Polyomavirus-associated nephropathy;Transplant rejection;Viraemia,237571241,OT,,,,,,,,,237571241,1,Renal transplant
23757286,237572861,1,I,,20240403,20240418,20240418,EXP,,DE-AUROBINDO-AUR-APL-2024-017247,AUROBINDO,"Foerster Y, Sollfrank L, Rechtien L, Harrer T, Berking C, Sticherling M. Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature. Frontiers-in Immunology. 2023;14:1-6",74,YR,,F,Y,,,20240418,,HP,DE,DE,EFAVIRENZ,Pemphigoid,237572861,HO,,,,,,,,,237572861,1,HIV infection
23758447,237584472,2,F,,20240424,20240418,20240503,EXP,,DE-TEVA-VS-3183881,TEVA,"Foerster Y, Sollfrank L, Rechtien L, Harrer T, Berking C, Sticherling M. Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature. Front-Immunol 2023; 14 1-6.; Foerster Y, Sollfrank L, Rechtien L, Harrer T, Berking C, Sticherling M. Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature. Front-Immunol 2023; 14 1-6.",74,YR,,F,Y,,,20240503,,HP,DE,DE,EFAVIRENZ,Pemphigoid,237584472,HO,,,,,,,,,237584472,1,HIV infection
23760545,237605452,2,F,20001023,20240619,20240419,20240621,EXP,,JP-VIIV HEALTHCARE LIMITED-A20017641,VIIV,,,,,,Y,,,20240621,,MD,JP,JP,EFAVIRENZ,Intracranial aneurysm;Liver function test abnormal;Osteoporosis;Progressive multifocal leukoencephalopathy;Spinal compression fracture,237605452,DE,,,237605452,1,20000619,20110925,4115,DAY,237605452,1,HIV infection
23763234,237632341,1,I,,20240408,20240419,20240419,EXP,,PHHY2017FR021402,NOVARTIS,"Barthelemy A, Bouvier N, Verdon R, Chatelet V, Hurault de Ligny B.. Successful renal retransplantation after graft loss from BK polyomavirus infection in a human immunodeficiency virus-positive patient. TRANSPLANT INFECTIOUS DISEASE. 2016;18 (6):946-9",51,YR,,M,Y,,,20240419,,HP,FR,FR,EFAVIRENZ,BK virus infection;Disease recurrence;Graft complication;Histology abnormal;Transplant rejection,237632341,HO,,,,,,,,,237632341,1,Immunosuppression
23765759,237657592,2,F,,20240418,20240421,20240503,EXP,,FR-AUROBINDO-AUR-APL-2017-30016,AUROBINDO,"Barth?lemy A,  Bouvier N, Verdon R, Chatelet V, Hurault de Ligny B.. Successful renal retransplantation after graft loss from BK polyomavirus infection in a human immunodeficiency virus-positive patient. Transplant Infectious Disease. 2016;18(6):946-9",51,YR,,M,Y,,,20240503,,MD,FR,FR,EFAVIRENZ,BK virus infection;Donor specific antibody present;Graft complication;Histology abnormal;Nephropathy;Neutropenia;Polyomavirus-associated nephropathy;Transplant failure;Viraemia;Viral test positive,237657592,OT,,,237657592,8,,,150,DAY,237657592,1,Immunosuppression
23766690,237666901,1,I,,20240408,20240422,20240422,EXP,,FR-SANDOZ INC.-PHHY2017FR021402,SANDOZ,,51,YR,,M,Y,,,20240422,,MD,FR,FR,EFAVIRENZ,BK virus infection;Disease recurrence;Graft complication;Histology abnormal;Transplant rejection,237666901,HO,,,,,,,,,237666901,2,Renal transplant
23770220,237702201,1,I,,20240412,20240422,20240422,EXP,,MY-MYLANLABS-2024M1035230,MYLAN,"Rahman RA, Hashim SM , Jalal JIA. Implant Failure Resulting In An Unintended Pregnancy In A Woman Living With Hiv: A Case Report. Brunei-Int-Med-J 2024; 20 24-28.",32,YR,,F,Y,,,20240422,,HP,MY,MY,EFAVIRENZ,Abortion spontaneous;Drug interaction;Maternal exposure during pregnancy;Pregnancy with injectable contraceptive,237702201,OT,,,,,,,,,237702201,1,HIV infection
23774096,237740961,1,I,,20240422,20240423,20240423,EXP,,FR-SANDOZ INC.-SDZ2024FR041952,SANDOZ,,51,YR,,M,Y,,,20240423,,MD,FR,FR,EFAVIRENZ,BK virus infection;Neutropenia,237740961,OT,,,237740961,8,,,4,DAY,237740961,3,Product used for unknown indication
23776671,237766711,1,I,,20240412,20240424,20240424,EXP,,US-CIPLA (EU) LIMITED-2024US03893,CIPLA,"Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K.. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: A case series. The American Journal of the Medical Science. 2024;367 (S1):S9 to S10",,,,,Y,,,20240424,,HP,US,US,EFAVIRENZ,Endocrine ophthalmopathy;Graves' disease,237766711,OT,,,,,,,,,237766711,1,HIV infection
23778979,237789791,1,I,,20240318,20240424,20240424,EXP,,BR-GILEAD-2024-0670573,GILEAD,"Coelho L, Chazallon C., Laureillard D., Escada R., N^Takpe J, Timana I etal. Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial. Open Forum Infectious Diseases. 2024;11(3):unk. doi:10.1093/ofid/ofae035",,,A,,Y,,,20240424,,HP,BR,BR,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,237789791,OT,,,,,,,,,237789791,1,HIV infection
23779122,237791221,1,I,,20240318,20240424,20240424,EXP,,BR-GILEAD-2024-0670576,GILEAD,"Coelho L, Chazallon C., Laureillard D., Escada R., N^Takpe J, Timana I.. Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial. Open Forum Infectious Diseases. 2024;11(3):unk. doi:10.1093/ofid/ofae035",,,A,,Y,,,20240424,,HP,BR,BR,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,237791221,DE,,,,,,,,,237791221,1,HIV infection
23779226,237792261,1,I,,20240318,20240424,20240424,EXP,,BR-GILEAD-2024-0670577,GILEAD,"Coelho L, Chazallon C., Laureillard D., Escada R., N^Takpe J, Timana I etal. Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial. Open Forum Infectious Diseases. 2024;11(3):Unk. doi:10.1093/ofid/ofae035",,,A,,Y,,,20240424,,HP,BR,BR,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,237792261,DE,,,,,,,,,237792261,1,HIV infection
23782631,237826311,1,I,,20240415,20240425,20240425,PER,,US-PFM-2024-02407,PIERRE FABRE MEDICAMENT,"Woods H, Bharathidasan K, Yang M, Nichols J, Nugent K. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: a case series. The American journal of the medical sciences. 2024;9-10",51,YR,,F,Y,,,20240425,,HP,US,US,EFAVIRENZ\EMTRICITABINE\TENOFOVIR,Endocrine ophthalmopathy;Off label use;Product use in unapproved indication;Product use issue,237826311,OT,,,,,,,,,237826311,1,Graves' disease
23785390,237853901,1,I,,20240424,20240425,20240425,EXP,,CA-SANDOZ INC.-NVSC2023CA035182,SANDOZ,,44,YR,,M,Y,,,20240425,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,237853901,HO,,,237853901,2,,,2,DAY,237853901,1,Depression
23785586,237855862,2,F,,20240503,20240425,20240509,EXP,,CA-SANDOZ INC.-SDZ2024CA042522,SANDOZ,,44,YR,,M,Y,,,20240507,,CN,CA,CA,EFAVIRENZ,Depression;Drug interaction,237855862,HO,,,237855862,4,,,354,DAY,237855862,1,Mental disorder
23792851,237928512,2,F,,20240518,20240429,20240524,EXP,,KZ-HETERO-HET2024KZ01205,HETERO,,,,A,F,Y,,,20240524,,HP,KZ,KZ,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Nephropathy toxic,237928512,OT,,,237928512,1,20200604,20240307,1373,DAY,237928512,1,HIV infection
23792942,237929421,1,I,20240306,20240426,20240429,20240429,EXP,FR-AFSSAPS-MA2024000713,FR-VIIV HEALTHCARE LIMITED-FR2024053948,VIIV,,,,,,Y,,,20240429,,MD,FR,FR,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Hepatic cytolysis,237929421,LT,,,237929421,1,20240212,20240306,23,DAY,237929421,1,HIV infection
23798164,237981641,1,I,,20240422,20240430,20240430,EXP,,ZA-AstraZeneca-2024A096417,ASTRAZENECA,,49,YR,,M,Y,,,20240430,,CN,ZA,,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Gait inability;Road traffic accident,237981641,OT,,,,,,,,,237981641,1,Diabetes mellitus
23800135,238001351,1,I,20170701,20240423,20240430,20240430,EXP,,CN-GSK-CN2024APC051498,GLAXOSMITHKLINE,,,,,,Y,,,20240430,,HP,CN,CN,EFAVIRENZ,Dermatitis allergic;Discomfort;Disease recurrence;Drug eruption;Erythema;Pruritus;Rash;Rash maculo-papular;Skin exfoliation;Skin warm,238001351,HO,,,238001351,1,20240415,20240419,4,DAY,238001351,1,HIV infection
23800136,238001361,1,I,20170701,20240423,20240430,20240430,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2024APC051498,VIIV,,,,,,Y,,,20240430,,HP,CN,CN,EFAVIRENZ,Dermatitis allergic;Discomfort;Disease recurrence;Drug eruption;Erythema;Pruritus;Rash;Rash maculo-papular;Skin exfoliation;Skin warm,238001361,HO,,,238001361,1,20240415,20240419,4,DAY,238001361,1,HIV infection
23804672,238046724,4,F,20220915,20240513,20240501,20240517,EXP,,MY-ORGANON-O2404MYS003497,ORGANON,"Rahman R.A., Hashim S.M., Jalal J.I.A.. IMPLANT FAILURE RESULTING IN AN UNINTENDED PREGNANCY IN A WOMAN LIVING WITH HIV: A CASE REPORT. Brunei International Medical Journal. 2024;20:24-8",32,YR,,F,Y,95,KG,20240517,,MD,MY,MY,EFAVIRENZ,Abortion spontaneous;Depressive symptom;Drug interaction;Pregnancy with implant contraceptive;Treatment failure;Unintended pregnancy,238046724,OT,,,238046724,1,20211007,202307,,,238046724,1,Contraception
23808977,238089772,2,F,,20240429,20240502,20240513,EXP,,IN-GILEAD-2024-0671242,GILEAD,"Ranade R, Desai A., Mayya M, Patil S, Rani H., Revanasiddappa M. Clinicopathological study of pigment induced nephropathy; a retrospective study. Journal of Nephropathology. 2024;13(2):Unk. doi:10.34172/jnp.2022.17362",61,YR,A,M,Y,,,20240513,,HP,IN,IN,EFAVIRENZ,Acute kidney injury;Rhabdomyolysis,238089772,OT,,,,,,,,,238089772,1,HIV infection
23810301,238103011,1,I,,20240417,20240502,20240502,EXP,,CA-TEVA-VS-3192536,TEVA,,44,YR,,M,Y,,,20240502,,HP,CA,CA,EFAVIRENZ,Depression;Drug interaction,238103011,HO,,,238103011,7,,,354,DAY,238103011,1,Mental disorder
23810718,238107181,1,I,,20240422,20240502,20240502,EXP,,IR-BRISTOL-MYERS SQUIBB COMPANY-2024-063585,BRISTOL MYERS SQUIBB,"Moghimi M, Nekoukar Z, Khosravi N. Acute efavirenz intoxication in a 16-year-old HIV negative girl: a case report and literature review. Pharmaceutical and Biomedical Research. 2024 Jan 01;10(1):73-8. doi:10.32598/PBR.10.1.931.1.",16,YR,T,F,Y,,,20240502,,HP,IR,IR,EFAVIRENZ,Abdominal distension;Dizziness;Headache;Insomnia;Intentional overdose;Nausea;Pain,238107181,HO,,,,,,,,,238107181,1,Suicide attempt
23815575,238155751,1,I,,20240420,20240503,20240503,EXP,,RO-AUROBINDO-AUR-APL-2024-020526,AUROBINDO,,32,YR,,F,Y,50,KG,20240503,,MD,RO,RO,EFAVIRENZ,Arthralgia;Dermatitis contact;Drug intolerance;Dyslipidaemia;Hypertension;Myalgia;Pneumonia bacterial;Product availability issue;Toxocariasis;Toxoplasmosis;Weight decreased,238155751,OT,,,238155751,1,2008,2008,,,238155751,1,Product used for unknown indication
23824661,238246611,1,I,20231009,20240429,20240507,20240507,EXP,,DE-VIIV HEALTHCARE LIMITED-DE2023EME167263,VIIV,,,,,,Y,,,20240507,,MD,DE,DE,TENOFOVIR + EMTRICITABINE + EFAVIRENZ,Pathogen resistance;Viral mutation identified;Virologic failure,238246611,DS,,,238246611,1,20210805,20231009,795,DAY,238246611,1,HIV infection
23840300,238403001,1,I,,20240429,20240510,20240510,EXP,,CA-JNJFOC-20240507092,JOHNSON AND JOHNSON,,44,YR,A,M,Y,,,20240510,,HP,CA,CA,EFAVIRENZ,Depression;Drug interaction,238403001,HO,,,238403001,5,,,354,DAY,238403001,1,Mental disorder
23844058,238440581,1,I,20240306,20240430,20240510,20240510,EXP,FR-AFSSAPS-MA2024000713,FR-TEVA-VS-3193854,TEVA,,29,YR,,M,Y,,,20240510,,MD,FR,FR,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Hepatic cytolysis,238440581,LT,,,238440581,1,20240212,20240306,23,DAY,238440581,1,HIV infection
23857525,238575251,1,I,,20240503,20240515,20240515,EXP,CA-MHPD-001081816,CA-Accord-424034,ACCORD,,44,YR,A,M,Y,,,20240515,,HP,CA,CA,EFAVIRENZ,Depression;Drug interaction,238575251,HO,,,238575251,5,,,354,DAY,238575251,1,Mental disorder
23858202,238582021,1,I,20240415,20240508,20240515,20240515,EXP,,UA-MYLANLABS-2024M1042522,MYLAN,,45,YR,,M,Y,,,20240515,,HP,UA,UA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Nephropathy toxic,238582021,OT,,,238582021,1,20220523,20240416,695,DAY,238582021,1,HIV infection
23862190,238621901,1,I,20060101,20240510,20240516,20240516,EXP,,US-GILEAD-2024-0672501,GILEAD,,35,YR,A,F,Y,,,20240516,,CN,US,US,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Arthritis;Back disorder;Musculoskeletal discomfort;Pain,238621901,DS,,,,,,,,,238621901,1,HIV infection
23867864,238678641,1,I,,20240509,20240517,20240517,EXP,,LV-VIIV HEALTHCARE LIMITED-LV2024EME060337,VIIV,,,,,,Y,,,20240517,,HP,LV,LV,EFAVIRENZ,Coronary artery disease;Myocardial infarction,238678641,OT,,,,,,,,,238678641,1,Product used for unknown indication
23867865,238678651,1,I,,20240509,20240517,20240517,EXP,,LV-GSK-LV2024EME060337,GLAXOSMITHKLINE,,,,,,Y,,,20240517,,HP,LV,LV,EFAVIRENZ,Coronary artery disease;Myocardial infarction,238678651,OT,,,,,,,,,238678651,1,Product used for unknown indication
23868149,238681491,1,I,20240503,20240507,20240517,20240517,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2024APC058005,VIIV,,,,,,Y,,,20240517,,HP,CN,CN,EFAVIRENZ,Agitation;Insomnia;Myelosuppression;Nausea;Palpitations;Vomiting,238681491,OT,,,238681491,1,20240502,20240502,,,238681491,1,Antiretroviral therapy
23868154,238681541,1,I,20240503,20240507,20240517,20240517,EXP,,CN-GSK-CN2024APC058005,GLAXOSMITHKLINE,,,,,,Y,,,20240517,,HP,CN,CN,EFAVIRENZ,Agitation;Insomnia;Myelosuppression;Nausea;Palpitations;Vomiting,238681541,OT,,,238681541,1,20240502,20240502,,,238681541,1,Antiretroviral therapy
23870431,238704311,1,I,20240328,20240511,20240518,20240518,EXP,,RU-AMAROX PHARMA-HET2024RU01436,HETERO,,,,,M,Y,51,KG,20240518,,MD,RU,RU,EFAVIRENZ,Renal impairment,238704311,OT,,,238704311,1,20240221,20240328,37,DAY,238704311,1,HIV infection
23889003,238890031,1,I,,20240520,20240523,20240523,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2024-080547,BRISTOL MYERS SQUIBB,,,,,,Y,,,20240523,,CN,US,US,EFAVIRENZ,Daydreaming,,,,,,,,,,,238890031,1,Product used for unknown indication
23893983,238939831,1,I,,20240511,20240524,20240524,EXP,,US-CIPLA (EU) LIMITED-2024US05217,CIPLA,"Kopp CM, Sobhani NC, Baker B, Tapia K, Jain R, Hitti J et al. Antiretroviral regimen and pregnancy outcomes of women living with Human immunodeficiency virus in a US cohort.. Infectious Diseases in Clinical Practice. 2023;31 (6): e1308:1 to 8",,,,,Y,,,20240524,,HP,US,US,EFAVIRENZ,Cranial nerve paralysis;Foetal exposure during pregnancy,238939831,OT,,,,,,,,,,,
23896240,238962401,1,I,20240501,20240520,20240523,20240523,DIR,FDA-CDER-CTU-2024-37182,,FDA-CTU,,52,YR,,M,N,,,20240520,N,HP,US,,EFAVIRENZ,Viral infection,238962401,HO,238962401,HP,238962401,1,202404,,,,238962401,1,HIV infection
23910528,239105281,1,I,20230101,20231015,20240528,20240528,PER,,US-PERRIGO-23US012084,PERRIGO,,57,YR,,M,Y,81.633,KG,20240528,,CN,US,US,SUSTIVA,Application site papules;Inappropriate schedule of product administration,,,,,239105281,1,202201,202304,,,239105281,1,Alopecia
23911792,239117921,1,I,,20240522,20240528,20240528,EXP,,LV-MYLANLABS-2024M1047193,MYLAN,,43,YR,,M,Y,,,20240528,,HP,LV,LV,EFAVIRENZ,Coronary artery disease;Myocardial infarction,239117921,OT,,,,,,,,,239117921,1,Product used for unknown indication
23912014,239120141,1,I,,20240524,20240528,20240528,EXP,LV-VIIV HEALTHCARE ULC-LV2024EME060337,LV-009507513-2405LVA008147,MERCK,,43,YR,,M,Y,,,20240528,,HP,LV,LV,EFAVIRENZ,Coronary artery disease;Myocardial infarction,239120141,OT,,,,,,,,,239120141,1,Product used for unknown indication
23921652,239216521,1,I,20200312,20240520,20240530,20240530,EXP,,RU-GILEAD-2024-0674846,GILEAD,,41,YR,A,F,Y,77,KG,20240530,,HP,RU,RU,EFAVIRENZ,Dermatitis allergic,239216521,OT,,,239216521,1,20200212,20200313,30,DAY,239216521,1,HIV infection
23921891,239218911,1,I,20160101,20240520,20240530,20240530,EXP,,RO-009507513-2405ROU006794,MERCK,,28,YR,,F,Y,,,20240530,,MD,RO,RO,EFAVIRENZ,Aortic arteriosclerosis;Blood HIV RNA increased;CD4 lymphocytes decreased;Coeliac artery stenosis;Drug resistance mutation;Duodenitis;Lymphadenopathy;Mental fatigue;Mesenteric artery stenosis;Psychotherapy;Renal artery stenosis;Treatment noncompliance,239218911,OT,,,,,,,,,239218911,1,HIV infection
23956005,239560051,1,I,,20240529,20240610,20240610,EXP,,KE-MACLEODS PHARMA-MAC2024047519,MACLEODS,"Odhiambo F, Nareeba S, Mwangeka G, Njambi A, Nyakebati V..Tenofovir induced Fanconi syndrome in a middle age African female from Kenya, East Africa: Case report and brief literature review.Clinical Case Reports.24-MAY-2024;12(6):e8889:1-5",,,,,Y,,,20240610,,HP,KE,KE,EFAVIRENZ,Fanconi syndrome;Nephropathy toxic,239560051,HO,,,239560051,2,2011,2019,,,239560051,1,HIV infection
23961478,239614781,1,I,,20240606,20240611,20240611,EXP,,GH-MYLANLABS-2024M1052645,MYLAN,"Puplampu P, Asamoah I, Asare BO, Berko KP, Oladele O, Amankwa E, et al. Cryptococcal meningitis among perinatally HIV-infected adolescents: Case series on presentation and management challenges. Clin-Case-Rep 2023; 11 (2): e6995.",,,,F,Y,,,20240611,,HP,GH,GH,EFAVIRENZ,Meningitis cryptococcal;Treatment noncompliance,239614781,HO,,,,,,,,,239614781,1,Perinatal HIV infection
23966342,239663421,1,I,,20240606,20240612,20240612,EXP,,GH-MYLANLABS-2024M1052744,MYLAN,"Puplampu P, Asamoah I, Asare BO, Berko KP, Oladele O, Amankwa E, et al. Cryptococcal meningitis among perinatally HIV-infected adolescents: Case series on presentation and management challenges. Clin-Case-Rep 2023; 11 (2): e6995.",,,T,F,Y,,,20240612,,HP,GH,GH,EFAVIRENZ,Meningitis cryptococcal;Treatment noncompliance,239663421,DE,,,,,,,,,239663421,1,Perinatal HIV infection
23971329,239713291,1,I,,20240606,20240613,20240613,EXP,,GH-STRIDES ARCOLAB LIMITED-2024SP006673,STRIDES,"Puplampu P, Asamoah I, Asare BO, Berko KP, Oladele O, Amankwa E, et al. Cryptococcal meningitis among perinatally HIV-infected adolescents: Case series on presentation and management challenges.. Clin-Case-Rep. 2023;11(2):e6995",,,,F,Y,,,20240613,,HP,GH,GH,EFAVIRENZ,Meningitis cryptococcal;Treatment noncompliance,239713291,DE,,,,,,,,,239713291,1,Perinatal HIV infection
23971351,239713511,1,I,,20240606,20240613,20240613,EXP,,GH-STRIDES ARCOLAB LIMITED-2024SP006675,STRIDES,"Puplampu P, Asamoah I, Asare BO, Berko KP, Oladele O, Amankwa E, et al.. Cryptococcal meningitis among perinatally HIV-infected adolescents: Case series on presentation and management challenges. Clin-Case-Rep. 2023;11(2):e6995",,,T,F,Y,,,20240613,,HP,GH,GH,EFAVIRENZ,Meningitis cryptococcal;Treatment noncompliance,239713511,DE,,,,,,,,,239713511,1,Perinatal HIV infection
23978611,239786111,1,I,20150101,20240605,20240614,20240614,EXP,,RO-009507513-2406ROU001779,MERCK,,41,YR,,F,Y,,,20240614,,MD,RO,RO,EFAVIRENZ,Carotid arteriosclerosis;Cerebrovascular accident;Coma;Coronary artery disease;Dyslipidaemia;Hypertension;Transient ischaemic attack;Treatment failure;Weight increased,239786111,HO,,,239786111,1,2015,2013,,,239786111,1,Antiretroviral therapy
24012609,240126091,1,I,,20240621,20240626,20240626,EXP,,CA-SANDOZ INC.-SDZ2024CA059990,SANDOZ,,54,YR,,M,Y,,,20240626,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,240126091,OT,,,,,,,,,240126091,1,HIV infection
24018029,240180291,1,I,20150101,20240617,20240627,20240627,EXP,,RO-AUROBINDO-AUR-APL-2024-030588,AUROBINDO,,41,YR,,F,Y,,,20240627,,MD,RO,RO,EFAVIRENZ,Carotid arteriosclerosis;Cerebrovascular accident;Coma;Coronary artery disease;Dyslipidaemia;Hypertension;Transient ischaemic attack;Treatment failure;Weight increased,240180291,HO,,,240180291,1,201205,2013,,,240180291,1,Antiretroviral therapy
24020251,240202511,1,I,,20240620,20240627,20240627,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2024APC077427,VIIV,,,,,,Y,,,20240627,,HP,CN,CN,EFAVIRENZ,Arthralgia;Condition aggravated;Pruritus;Rash;Skin infection;Skin ulcer,240202511,HO,,,240202511,1,20100501,20240601,169,MON,240202511,1,Acquired immunodeficiency syndrome
24023203,240232031,1,I,20230901,20240314,20240627,20240627,PER,,PE-ROCHE-3528396,ROCHE,,36,YR,A,M,Y,74,KG,20240628,,MD,PE,PE,EFAVIRENZ,Chronic kidney disease,,,,,240232031,1,20220505,,,,240232031,1,Non-small cell lung cancer metastatic
24027453,240274531,1,I,,20240625,20240628,20240628,EXP,,ZA-AstraZeneca-2024A147924,ASTRAZENECA,,51,YR,,M,Y,,,20240628,,CN,ZA,,EFAVIRENZ\EMTRICITABINE\TENOFOVIR\TENOFOVIR DISOPROXIL FUMARATE,Cardiac disorder,240274531,LT,,,,,,,,,240274531,1,Diabetes mellitus
24029098,240290981,1,I,,20240625,20240628,20240628,EXP,,MY-MYLANLABS-2024M1060440,MYLAN,,25,YR,,M,Y,,,20240628,,MD,MY,MY,EFAVIRENZ,Erectile dysfunction,240290981,OT,,,,,,,,,240290981,1,Antiretroviral therapy
24031924,240319241,1,I,,20240626,20240629,20240629,EXP,,IN-AMGEN-INDSP2024127150,AMGEN,Yadav A.. Pemphigus vulgaris in association with human immunodeficiency virus infection: A management dilemma. Indian Journal of Sexually Transmitted Diseases and AIDS. 2024;45 (1):62-64,50,YR,A,F,Y,,,20240629,,MD,IN,IN,EFAVIRENZ,Blood urea increased;Cardiac arrest;Enterococcal infection;Hepatic enzyme increased;Metabolic acidosis;Off label use;Pemphigus;Prerenal failure;Sepsis,240319241,DE,,,240319241,3,201408,,,,240319241,1,Pemphigus
6753908,675390823,23,F,20060602,20240618,20080911,20240621,EXP,,CA-MERCK-0809CAN00002,MERCK,"Harris M, Larsen G, Montaner JSG. Harris M, Larsen G, Montaner JSG. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22 (14):1890-2. AIDS. 2008;22 (14):1890-2",44,YR,,M,Y,,,20240621,,MD,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,675390823,HO,,,675390823,1,20070626,20070626,2,DAY,675390823,1,HIV infection
7302622,730262249,49,F,,20240618,20100302,20240628,EXP,,CA-MERCK-0907CAN00093,MERCK,"Pfeffer G, Mezei MM, Montaner JS, Li CC, Jitratkosol M, Cote HC. Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy. NEUROLOGY. 2009;73(1):71-2",52,YR,,M,Y,,,20240628,,MD,CA,CA,EFAVIRENZ;SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia;Progressive external ophthalmoplegia,730262249,OT,,,730262249,1,200802,200802,91,DAY,730262249,1,HIV infection
7609977,760997732,32,F,20061128,20240325,20100928,20240402,EXP,,JP-JNJFOC-20100907113,JOHNSON AND JOHNSON,,49,YR,A,M,Y,,,20240402,,MD,JP,JP,EFAVIRENZ,Anaemia;Drug resistance;Dyslipidaemia;Hepatocellular carcinoma;Hyperbilirubinaemia;Osteoporosis;Pyelonephritis,760997732,HO,,,760997732,1,20061111,20240202,7,YR,760997732,1,HIV infection
